Assignee
FREENOME HOLDINGS INC
US·11 granted patents·21 pending applications·63 citations·filing 2017–2025
Top patents by PatentIndex Score
32 records- 0195US11781959B2Methods and systems for sample extractionFREENOME HOLDINGS INC·Filed 2020·Granted Oct 10, 2023·6 cites·10 claims
- 0294US11847532B2Machine learning implementation for multi-analyte assay development and testingFREENOME HOLDINGS INC·Filed 2021·Granted Dec 19, 2023·10 cites·7 claims
- 0392US11681953B2Machine learning implementation for multi-analyte assay development and testingFREENOME HOLDINGS INC·Filed 2019·Granted Jun 20, 2023·15 cites·18 claims
- 0492US11514289B1Generating machine learning models using genetic dataFREENOME HOLDINGS INC·Filed 2017·Granted Nov 29, 2022·32 cites·23 claims
- 0581US2026085351A1Methods and systems for high-depth sequencing of methylated nucleic acidFREENOME HOLDINGS INC·Filed 2025·Application pending·0 cites
- 0676US12247905B2Methods and systems for sample extractionFREENOME HOLDINGS INC·Filed 2023·Granted Mar 11, 2025·0 cites·12 claims
- 0776US2026028680A1Methods and systems for detecting colorectal cancer via nucleic acid methylation analysisFREENOME HOLDINGS INC·Filed 2025·Application pending·0 cites
- 0875US12454724B2Methods and systems for high-depth sequencing of methylated nucleic acidFREENOME HOLDINGS INC·Filed 2023·Granted Oct 28, 2025·0 cites·16 claims
- 0974US2024202603A1Machine learning implementation for multi-analyte assay development and testingFREENOME HOLDINGS INC·Filed 2023·Application pending·0 cites
- 1073US12410480B2Methods and systems for detecting colorectal cancer via nucleic acid methylation analysisFREENOME HOLDINGS INC·Filed 2023·Granted Sep 9, 2025·0 cites·13 claims
- 1172US12242943B2Generating machine learning models using genetic dataFREENOME HOLDINGS INC·Filed 2022·Granted Mar 4, 2025·0 cites·27 claims
- 1272US2023175058A1Methods and systems for abnormality detection in the patterns of nucleic acidsFREENOME HOLDINGS INC·Filed 2023·Application pending·0 cites
- 1371US2025369972A1Markers for the early detection of colon cell proliferative disordersFREENOME HOLDINGS INC·Filed 2025·Application pending·0 cites
- 1470US12228574B2Markers for the early detection of colon cell proliferative disordersFREENOME HOLDINGS INC·Filed 2023·Granted Feb 18, 2025·0 cites·20 claims
- 1570US2025122563A1Methods and compositions of nucleic acid molecule enrichment for sequencingFREENOME HOLDINGS INC·Filed 2024·Application pending·0 cites
- 1667US12372528B2Markers for the early detection of colon cell proliferative disordersFREENOME HOLDINGS INC·Filed 2023·Granted Jul 29, 2025·0 cites·13 claims
- 1767US2024240257A1Compositions and methods for improved 5-hydroxymethylated cytosine resolution in nucleic acid sequencingFREENOME HOLDINGS INC·Filed 2024·Application pending·0 cites
- 1866US12503728B2Methods and systems for high-depth sequencing of methylated nucleic acidFREENOME HOLDINGS INC·Filed 2021·Granted Dec 23, 2025·0 cites·18 claims
- 1966US2025122575A1Sequence process validation methods and compositionsFREENOME HOLDINGS INC·Filed 2024·Application pending·0 cites
- 2064US2025146081A1Tcr/bcr profiling for cell-free nucleic acid detection of cancerFREENOME HOLDINGS INC·Filed 2024·Application pending·0 cites
- 2163US2021010076A1Methods and systems for abnormality detection in the patterns of nucleic acidsFREENOME HOLDINGS INC·Filed 2020·Application pending·0 cites
- 2262US2025156674A1Generating machine learning models using genetic dataFREENOME HOLDINGS INC·Filed 2025·Application pending·0 cites
- 2362US2023101485A1Methods and systems for detecting colorectal cancer via nucleic acid methylation analysisFREENOME HOLDINGS INC·Filed 2022·Application pending·0 cites
- 2462US2025224400A1Markers for the early detection of colon cell proliferative disordersFREENOME HOLDINGS INC·Filed 2025·Application pending·0 cites
- 2560US2025164492A1Markers for the early detection of colon cell proliferative disordersFREENOME HOLDINGS INC·Filed 2024·Application pending·0 cites
- 2659US2021272653A1Transcription factor profilingFREENOME HOLDINGS INC·Filed 2021·Application pending·0 cites
- 2757US2024084397A1Methods and systems for detecting cancer via nucleic acid methylation analysisFREENOME HOLDINGS INC·Filed 2023·Application pending·0 cites
- 2854US2023178181A1Methods and systems for detecting cancer via nucleic acid methylation analysisFREENOME HOLDINGS INC·Filed 2023·Application pending·0 cites
- 2953US2023160019A1Rna markers and methods for identifying colon cell proliferative disordersFREENOME HOLDINGS INC·Filed 2022·Application pending·0 cites
- 3053US2024289586A1Diagnostic data feedback loop and methods of use thereofFREENOME HOLDINGS INC·Filed 2023·Application pending·0 cites
- 3148US2021057046A1Methods and systems for analyzing microbiotaFREENOME HOLDINGS INC·Filed 2020·Application pending·0 cites
- 3241US2025305061A1Methods and systems for inferring gene expression using cell-free dna fragmentsFREENOME HOLDINGS INC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →